GET THE APP

The Biology of SARS-CoV-2 | 58804

Allgemeinmedizin: Open Access

ISSN - 2327-5146

Abstrakt

The Biology of SARS-CoV-2

Sintayehu Tseha

Coronavirus disease 2019 (COVID-2019) is a newly emerged infectious disease that has caused the deaths of 657, 643 in the world (CNN, July 2020). The emergence of this novel disease was first identified in patients presented with pneumonia in Wuhan, Hubei, China, in December 2019 and this novel disease was named by WHO as COVID-19 on February 11 (Guo et al; 2020; Tian et al; 2020; Zhao et al., 2020). On the same day, the international virus classification commission announced that the novel coronavirus was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Zhou et al; 2020). The disease was declared as a pandemic by the World Health Organization (WHO) on March 11, 2020 (Li et al; 2020). As of July 27/2020, 16, 605, 067 people were confirmed to have COVID-19, with 520, 499 deaths worldwide (CNN, 2020). In Ethiopia, as of July 28, 2020, a total of 15, 200 COVID-19 cases and 239 deaths due to the disease have been documented (ETV, 2020). The aim of this review is to discuss what is so far known and unknown to better contain and or mitigate COVID-19.

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert